PMID: 1682683Nov 23, 1991Paper

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

Lancet
B DahlöfP O Wester

Abstract

Although the benefits of antihypertensive treatment in "young" elderly (under 70 years) hypertensive patients are well established, the value of treatment in older patients (70-84 years) is less clear. The Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) was a prospective, randomised, double-blind, intervention study set up to compare the effects of active antihypertensive therapy (three beta-blockers and one diuretic) and placebo on the frequency of fatal and non-fatal stroke and myocardial infarction and other cardiovascular death in hypertensive Swedish men and women aged 70-84 years. We recruited 1627 patients at 116 health centres throughout Sweden, who were willing to participate, and who met the entry criteria of three separate recordings during a 1-month placebo run-in period of systolic blood pressure between 180 and 230 mm Hg with a diastolic pressure of at least 90 mm Hg, or a diastolic pressure between 105 and 120 mm Hg irrespective of the systolic pressure. The total duration of the study was 65 months and the average time in the study was 25 months. 812 patients were randomly allocated active treatment and 815 placebo. The mean difference in supine blood pressure between the active treatment and...Continue Reading

References

Nov 1, 1986·British Medical Journal·J Coope, T S Warrender
Mar 26, 1988·British Medical Journal·K MattilaR Heikinheimo
Aug 1, 1986·Journal of Hypertension·B DahlöfP O Wester

❮ Previous
Next ❯

Citations

Dec 1, 1992·Cardiovascular Drugs and Therapy·L H Opie
Dec 1, 1992·Cardiovascular Drugs and Therapy·A AmeryP W de Leeuw
Dec 1, 1992·Cardiovascular Drugs and Therapy·P Lund-Johansen
Dec 1, 1992·Cardiovascular Drugs and Therapy·M Moser
Dec 1, 1992·Cardiovascular Drugs and Therapy·J I Robertson
Aug 1, 1994·Cardiovascular Drugs and Therapy·J I Robertson
Aug 1, 1993·Cardiovascular Drugs and Therapy·E G LakattaA H Gradman
Dec 1, 1993·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·M C Houston
Aug 1, 1995·Journal of General Internal Medicine·E J Pérez-StableD Feigal
Jun 1, 1996·Journal of General Internal Medicine·M A SekeresB L Strom
Dec 1, 1995·Journal of General Internal Medicine·D A Katzman, B Littenberg
Aug 18, 2004·Advances in Therapy·Massimo Volpe
Jan 1, 1998·Environmental Health and Preventive Medicine·F ShinshoT Takatorige
Jun 1, 1992·Aging : Clinical and Experimental Research·A Fletcher, C Bulpitt
Aug 1, 1994·Aging : Clinical and Experimental Research·H Agüero TorresB Winblad
Jan 4, 2008·Aging Clinical and Experimental Research·Maria Wendelin-SaarenhoviEino Hietanen
Apr 1, 2005·Der Internist·U Wenzel, G Wolf
Apr 19, 2005·Der Internist·A Hartmann, S Moskau
Aug 6, 2005·European Journal of Clinical Pharmacology·Elisabetta PoluzziNicola Montanaro
Nov 1, 2005·Zeitschrift für Kardiologie·G BönnerG Sauer
Jul 20, 2010·Wiener medizinische Wochenschrift·Ronald OttoMarkus Gosch
May 10, 2007·International Urology and Nephrology·Robert D Lindeman
Oct 16, 2002·Current Cardiology Reports·Ehud Grossman, Franz H Messerli
Mar 9, 2006·Current Diabetes Reports·Matthew BechtoldJames Sowers
Sep 10, 2013·Current Heart Failure Reports·Justin L Grodin, W H Wilson Tang
Sep 12, 2000·Current Hypertension Reports·C Vlachopoulos, M O'Rourke
Sep 12, 2000·Current Hypertension Reports·S P Glasser
May 17, 2001·Current Hypertension Reports·L M Ruilope
Sep 12, 2001·Current Hypertension Reports·E Grossman, U Goldbourt
Oct 3, 2001·Current Hypertension Reports·W C Cushman
Jul 27, 2001·Current Hypertension Reports·J G Wang, J A Staessen
May 11, 2002·Current Hypertension Reports·Anne-Sophie RigaudFrançoise Forette
Sep 10, 2002·Current Hypertension Reports·Clive Rosendorff
Jul 8, 2003·Current Hypertension Reports·Ji-Guang WangAnthony M Heagerty
May 7, 2004·Current Hypertension Reports·Olivier HanonFrançoise Forette
Sep 13, 2006·Current Hypertension Reports·Gordon S Stokes
Jul 16, 2008·Current Hypertension Reports·Giuseppe Mancia, Guido Grassi
Aug 17, 2010·Current Hypertension Reports·Bo Carlberg, Peter M Nilsson
Jun 18, 2011·Current Hypertension Reports·Debbie L Cohen, Raymond R Townsend
Aug 21, 2013·Current Hypertension Reports·Wilbert S Aronow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.